Form D · Biotechnology
Compvide Inc.
Renton, WA · CIK 0002105460
Offering snapshot reported Feb 3, 2026 · SEC filing
- Reported sold
- $25K Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 5, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2026 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-572147
Source: Form D, filed Feb 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sadam Yaseen | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
879 Rainier Ave N Ste A103
Renton, WA, 98057
Renton, WA, 98057